Xspray Pharma AB (publ) (LON:0GHZ)

London flag London · Delayed Price · Currency is GBP · Price in SEK
27.00
-0.40 (-1.46%)
At close: Mar 26, 2026
Market Cap91.10M +5.8%
Revenue (ttm)n/a
Net Income-13.82M
EPS-0.36
Shares Outn/a
PE Ration/a
Forward PE2.74
Dividendn/a
Ex-Dividend Daten/a
Volume176
Average Volume3,784
Open26.80
Previous Close27.40
Day's Range26.15 - 27.00
52-Week Range24.70 - 61.40
Beta0.82
RSI43.03
Earnings DateMar 26, 2026

About Xspray Pharma AB

Xspray Pharma AB (publ), a pharmaceutical company, engages in the development of protein kinase inhibitors for targeted cancer treatments in Sweden. The company develops Dasynoc, an amorphous version of dasatinib for the treatment of chronic myeloid leukemia (CML)and acute lymphoblastic leukemia; XS003, an amorphous non-crystalline nilotinib for the treatment of CML; XS008, an axitinib for the treatment of kidney cancer; and XS025, a amorphous non-crystalline cabozantinib for the treatment of renal cell carcinoma and other cancers. It has partn... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2003
Employees 26
Stock Exchange London Stock Exchange
Ticker Symbol 0GHZ

Financial Performance

Financial numbers in SEK Financial Statements